BANZEL
BANZEL
Approved
DIN Number
02369613
Drug Class
Human
Market Date
Oct 20, 2011
Company
HC
EISAI LIMITED
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02369613
AIG Number0152938001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AF03 RUFINAMIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
RUFINAMIDEActive
Strength: 100 MG
Monograph: RUFINAMIDE